Skip to content
ChatProjectCodes

Earlier editions: 2020-112018-112026-09

DIVISION 106. PERSONAL HEALTH CARE (INCLUDING MATERNAL, CHILD, AND ADOLESCENT) 123100-125850›PART 5. HEREDITARY DISEASES/CONGENITAL DEFECTS 124975-125292.10›CHAPTER 1. Genetic Prevention Services 124975-125119.5›ARTICLE 4. Prenatal Testing 125050-125119.5

§ 125100

California Health and Safety Code · 2026-10 edition · updated 2026-10-04 · California

(a) Clinical laboratories licensed by the department, approved public health laboratories, local health departments, physicians and surgeons, or other persons engaged in the prenatal care of a pregnant woman or in the care of an infant shall maintain and make available to the department information necessary to evaluate, for public health purposes, the effectiveness of testing and followup treatment for the prevention of perinatally transmitted hepatitis B infection.

(b) The department shall make available, to the extent state funds are appropriated therefor in the annual Budget Act or federal funds are available for that purpose, money to each county requesting funds for testing and followup treatment for the prevention of perinatally transmitted hepatitis B infection or for any functions performed pursuant to subdivision (a). The money shall be allocated by the department on the basis of the incidence of perinatally transmitted hepatitis B infection and the need for necessary followup treatment and evaluation in the requesting county.

(Added by Stats. 1995, Ch. 415, Sec. 8. Effective January 1, 1996.)

Get a plain-English answer with a citation back to this text.

Ask AI about this code
Export this section
▸Contents — California Health and Safety Code
California Health and Safety Code

GoCodebook provides public access, search, citation, multilingual explanation, and practical interpretation of legally adopted building regulations. It is not a substitute for the official ICC or California code publications.